Xiao Wang

Xiao Wang is a Clinical Assistant Professor in the Department of Medical Oncology and Hematology at the Yale School of Medicine. Their work focuses on oncology, hematology, and translational research in cancer treatment optimization. Education includes an MD from Johns Hopkins University School of Medicine and a BS from the University of Michigan. Board certified in Internal Medicine since 2021, they specialize in clinical care for patients with cancers such as non-small cell lung cancer, mesothelioma, and myeloid neoplasms.

Research interests emphasize genomic profiling in cancer care, targeted therapies, antibiotic stewardship in neutropenic fever management, and clinical outcomes of immunotherapies. Notable studies include analysis of KRAS G12C mutation outcomes in NSCLC and pembrolizumab efficacy in peritoneal mesothelioma.

Publications span oncology topics including biomarker testing patterns, molecular classification schemas, and real-world drug resistance mechanisms. Collaborations include multidisciplinary teams studying treatment algorithms and clinical trial design.